ZombieHealthcare
What Happened to Celularity?
Ticker: CELUSPAC Year: 2019
Return
-87.9%
Current Price
$1.21
Peak Price
$134
Trust Size
$114M
Summary
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived cell therapies for cancer, immune disorders, and degenerative diseases.
What Happened
Celularity went public in July 2021 through a merger with GX Acquisition Corp II. Founded by stem cell pioneer Robert Hariri, the company uses placental stem cells to develop allogeneic cell therapies that don't require patient-specific manufacturing. The company has reported going concern warnings and the stock has declined significantly, though it continues to advance its clinical pipeline.
Timeline
2019-05-13
S-1 Registration Filed